Thomas Stegmann insider trades: CardioVascular BioTherapeutics (CVBT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 11, 2009 | CVBT | ↓ Sell | 1,518,693 | $0.26 | $398K | Direct | Aug 18, 2009 (7d) |
| Aug 7, 2009 | CVBT | ↓ Sell | 3,969,400 | $0.17 | $691K | Direct | Aug 10, 2009 (3d) |
| Aug 3, 2009 | CVBT | ↓ Sell | 1,327,187 | $0.16 | $208K | Direct | Aug 4, 2009 (1d) |
| Jul 27, 2009 | CVBT | ↓ Sell | 1,634,100 | $0.15 | $246K | Direct | Jul 28, 2009 (1d) |
| Jul 20, 2009 | CVBT | ↓ Sell | 386,499 | $0.16 | $62K | Direct | Jul 21, 2009 (1d) |
| Jul 13, 2009 | CVBT | ↓ Sell | 345,225 | $0.18 | $62K | Direct | Jul 14, 2009 (1d) |
| Jul 6, 2009 | CVBT | ↓ Sell | 453,800 | $0.18 | $84K | Direct | Jul 7, 2009 (1d) |
| Jun 26, 2009 | CVBT | ↓ Sell | 582,770 | $0.19 | $111K | Direct | Jun 30, 2009 (4d) |
| Jun 19, 2009 | CVBT | ↓ Sell | 482,002 | $0.20 | $98K | Direct | Jun 23, 2009 (4d) |
| Jun 12, 2009 | CVBT.PK | ↓ Sell | 1,467,464 | $0.24 | $347K | Direct | Jun 17, 2009 (5d) |
| Apr 30, 2009 | CVBT.PK | ↓ Sell | 497,000 | $0.14 | $72K | Direct | May 14, 2009 (14d) |
| Apr 17, 2009 | CVBT.PK | ↓ Sell | 991,075 | $0.19 | $190K | Direct | Apr 29, 2009 (12d) |
| Dec 12, 2006 | CVBT | ↑ Buy | 30,000 | $1.10 | $33K | Direct | Dec 12, 2006 (0d) |
| Apr 3, 2006 | CVBT | ↑ Buy | 7,000 | $7.74 | $54K | Direct | Apr 4, 2006 (1d) |
| Mar 30, 2006 | CVBT | ↑ Buy | 2,250 | $7.70 | $17K | Direct | Mar 31, 2006 (1d) |
| Mar 22, 2006 | CVBT | ↑ Buy | 5,500 | $6.89 | $38K | Direct | Mar 24, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Thomas Stegmann's insider trades
Thomas Stegmann is a 10% owner of CardioVascular BioTherapeutics (CVBT). Since Mar 22, 2006, Thomas has reported 4 open-market purchases worth $142K and 12 sales worth $2.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CVBT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.